Literature DB >> 16985688

Caseating granulomas on the glans penis as a complication of bacille calmette-guérin intravesical therapy.

C G French, L Hickey, D G Bell.   

Abstract

Intravesical instillation of bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer or with carcinoma in situ of the bladder is a frequently used therapeutic option. As with other cancer therapies, BCG instillation has its share of side effects and complications. This case report highlights an uncommon complication.

Entities:  

Year:  2001        PMID： 16985688      PMCID： PMC1476030     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


  4 in total

1.  Mycobacterium bovis-BCG infection of the glans penis: a complication of intravesical administration of bacillus Calmette-Guerin.

Authors:  M Ribera; J Bielsa; J M Manterola; M T Fernández; C Ferrándiz
Journal:  Br J Dermatol       Date:  1995-02       Impact factor: 9.302

2.  Tuberculosis of the penis: report of 2 cases.

Authors:  B Agarwalla; G P Mohanty; L K Sahu; R C Rath
Journal:  J Urol       Date:  1980-12       Impact factor: 7.450

3.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

4.  Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.

Authors:  A P van der Meijden; K H Kurth; W Oosterlinck; F M Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  4 in total
  3 in total

1.  A late presentation of isolated lymph node tuberculosis postintravesical BCG therapy for superficial bladder cancer: a novel case.

Authors:  Ali Moostapha Tasleem; Branislav Varga; Wasim Mahmalji; Sanjeev Madaan
Journal:  BMJ Case Rep       Date:  2014-05-02

2.  Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy.

Authors:  Anadi Roy Chowdhury; Ranjan Kumar Dey
Journal:  Indian J Urol       Date:  2013-01

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.